Sustained Release Orally Disintegrating Tablets (ODTs) Comprising Microparticles to Improve Acceptability in Patients with Dysphagia
The development of patient-centric formulations for patients with dysphagia. Prepared ODTs showed promising-disintegration times(<30s)whilst allowing for sustained release and once-daily dosing.
Louis Weber
Louis Weber has spent his career within the contract development and manufacturing organization industry working for private, equity owned portfolio...
Gus LaBella
Gus LaBella, director of formulation development at Mikart, has over 30 years of experience in oral dosage form development. He...
Scott Neola
Scott Neola has spent his career working in accounting and finance for public accounting firms, Fortune 500 manufacturers, and, since...
Pharmaceutical Serialization and Aggregation
Serialization, the application of uniquely identifying codes to all levels of packaging, plays a vital role in fighting the growing...
Liquids and Suspensions
Oral non-sterile liquid manufacturing options offer a variety of liquid and suspension dosage solutions designed specifically around palatability — progressing...
Pharmaceutical Packaging Service
Mikart has a solid foundation in pharmaceutical packaging services with over 45 years of experience manufacturing flexible configurations. We offer...
Formulation Development
Once the unique properties of your drug substance are assessed, one of Mikart’s formulation experts is assigned to your project...